Items where authors include "Corradini, N."
Article
Moreno, L. orcid.org/0000-0002-0708-1670, Weston, R. orcid.org/0000-0002-7884-1884, Owens, C. et al. (87 more authors) (2024) Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial. Journal of Clinical Oncology, 42 (10). pp. 1135-1145. ISSN 0732-183X
Biteau, K., Guiho, R., Chatelais, M. et al. (5 more authors) (2016) L-MTP-PE and zoledronic acid combination in osteosarcoma: pre-clinical evidence of positive therapeutic combination for clinical transfer. American Journal of Cancer Research, 6 (3). 0025208. pp. 677-689. ISSN 2156-6976
Dumars, C., Nguyen, J.M., Gaultier, A. et al. (5 more authors) (2016) Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma. Oncotarget, 7. pp. 78343-78354. ISSN 0032-0889
Redini, F., Odri, G.A., Picarda, G. et al. (4 more authors) (2013) Drugs targeting the bone microenvironment: new therapeutic tools in Ewing's sarcoma? Expert Opinion on Emerging Drugs, 18 (3). pp. 339-352. ISSN 1472-8214
Battaglia, S., Dumoucel, S., Chesneau, J. et al. (6 more authors) (2011) Impact of Oncopediatric Dosing Regimen of Zoledronic Acid on Bone Growth: Preclinical Studies and Case Report of an Osteosarcoma Pediatric Patient. Journal of Bone and Mineral Research, 26 (10). pp. 2439-2451. ISSN 0884-0431
Ando, K., Mori, K., Corradini, N. et al. (2 more authors) (2011) Mifamurtide for the treatment of nonmetastatic osteosarcoma. Expert Opinion on Pharmacotherapy, 2 (12). pp. 285-292. ISSN 1465-6566
Odri, G.A., Dumoucel, S., Picarda, G. et al. (10 more authors) (2010) Zoledronic Acid as a New Adjuvant Therapeutic Strategy for Ewing's Sarcoma Patients. Cancer Research, 70 (19). pp. 7610-7619. ISSN 0008-5472